Theriva Biologics, Inc. Taxes Payable, Current
Theriva Biologics, Inc. (TOVX) had Taxes Payable, Current of $99.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2022-11-10
- 2022-09-30: Taxes Payable, Current $99.00K.
- 2022-06-30: Taxes Payable, Current $123.00K.
- 2022-03-31: Taxes Payable, Current $91.00K.
| Period end | Taxes Payable, Current |
|---|---|
| 2022-09-30 | $99.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $123.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $91.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |